Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors
(Q37187543)
scientific article published on 02 December 2008
scientific article published on 02 December 2008
Language: